The combination of rifampicin-erythromycin in the treatment of gonococcal urethritis in men.
D002439:Cefotaxime / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004917:Erythromycin / Q000008:administration & dosage* / Q000627:therapeutic use; D006069:Gonorrhea / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D009344:Neisseria gonorrhoeae / Q000187:drug effects / Q000201:enzymology; D010405:Penicillinase / Q000096:biosynthesis; D012293:Rifampin / Q000008:administration & dosage* / Q000627:therapeutic use; D014526:Urethritis / Q000188:drug therapy* / Q000382:microbiology
D004917:Erythromycin; D010405:Penicillinase; D002439:Cefotaxime; D012293:Rifampin